THE DAY, IN CONTEXTPolaris InsightsAn AI-powered comprehensive news portal

POLARIS INSIGHTS

Ginkgo reaffirms 2026 cash burn guidance of $125M-$150M while outlining first pharma autonomous lab sale to Novo Nordisk

This story focuses on Ginkgo reaffirms 2026 cash burn guidance of $125M-$150M while outlining first pharma….

Read the full account of the story

More from the Markets desk

More from Markets · Back to Polaris Insights